Glioblastoma Immunotherapy Trial: Hope for Newly Diagnosed Patients
A new trial using immunotherapy drug Ipilimumab (Yervoy) offers hope for glioblastoma patients. The drug enhances the immune system to fight cancer cells. A previous patient had clear scans after treatment.